Neue minimal-invasive Therapie des benignen Prostatasyndroms

Magistro, G.; Stief, C. G. und Gratzke, C. (2019): Neue minimal-invasive Therapie des benignen Prostatasyndroms. In: Urologe, Bd. 58, Nr. 3: S. 254-262

Abstract

Novel minimally invasive treatment options strive for innovative approaches that are equally efficient to standard procedures with asuperior safety profile. Atrue minimally invasive technique can be performed in an ambulatory setting under local anaesthesia and no need for postinterventional catheterization so that quick and problem-free return to everyday life is possible. Sexual dysfunction is agreat concern of sexually active patients facing surgery. The novel techniques clearly demonstrate that relief of bothersome lower urinary tract symptoms (LUTS) is possible without compromising erectile and ejaculatory function. Urolift (R) is an attractive treatment option for carefully selected patients without a middle lobe who have special interest in the rapid and smooth return to daily activity and the complete preservation of sexual function. Rezum (R) and AquaBeam (R) are promising novel techniques that can be also performed in the presence of certain prostatic features like amiddle lobe. iTIND (R) is still in its infancy of clinical evaluation and therefore, its true value still needs to be determined. According to current data the role of intraprostatic injectables for the treatment of male LUTS is still unclear.

• Dokumententyp: Zeitschriftenartikel
• Fakultät: Medizin
• Themengebiete: 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit
• ISSN: 0340-2592
• Sprache: Deutsch